The company
Johnson & Johnson
JNJ · NYSE
Health CarePharmaceuticalsIn trend
JNJ stood above a rising 150-day average in 52 of the last 52 weekly readings, every one of them. It is 2.8% above that average now. Pharmaceuticals: 31% of its 74 stocks in an uptrend (−7 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- In trend
- Weeks in an uptrend
- 52 in a row
- Industry in uptrend
- 31% -7 in 4 wk
- Insider buys, 12 months
- $258K
- Insider sales, 12 months
- $301.3M
- Officials’ trades on record
- 376
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 52 of 52 weeks.
17 Apr – 16 Oct
Pharmaceuticals: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
1 Nov 2024 – 1 Oct 2026
Open-market buys above the line and sales below, in dollars. Not yet read: institutions.
Congress and officials
376 disclosed lines: House 305, Senate 53, executive 18; 94 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Lloyd Doggett House: U.S. House ClerkTX37 | bought | $1k–$15k | 8 Sep 2026filed 5 Oct 2026 |
| Thomas H. Kean, Jr. House: U.S. House ClerkNJ07 | sold | $1k–$15k | 27 Aug 2026filed 12 Sep 2026 |
| John Boozman Senate: U.S. Senate eFDSenator | sold part ofjoint | $1k–$15k | 20 Aug 2026filed 11 Sep 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $100k–$250k | 31 Jul 2026filed 22 Sep 2026 |
| Richard McCormick House: U.S. House ClerkGA06 | sold | $1k–$15k | 30 Jul 2026filed 14 Aug 2026 |
| Thomas H. Kean, Jr. House: U.S. House ClerkNJ07 | sold | $1k–$15k | 29 Jun 2026filed 15 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 23 Jun 2026filed 22 Aug 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 16 Jun 2026filed 22 Aug 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $1k–$15k | 15 Jun 2026filed 22 Aug 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $100k–$250k | 12 Jun 2026filed 22 Aug 2026 |
| Lloyd Doggett House: U.S. House ClerkTX37 | bought | $1k–$15k | 9 Jun 2026filed 6 Jul 2026 |
| Thomas H. Kean, Jr. House: U.S. House ClerkNJ07 | sold | $1k–$15k | 2 Jun 2026filed 15 Jul 2026 |
Insiders
Buy orders, 12 months1
Sale orders, 12 months16
Buyers · sellers1 · 10
| Who | Did | Shares | Traded |
|---|---|---|---|
| Timothy SchmidEVP, WW Chair, MedTech | sold | 11,070at $274.74 | 2 Sep 2026filed 4 Sep 2026 |
| Timothy SchmidEVP, WW Chair, MedTech | sold | 22,527at $274.74 | 2 Sep 2026filed 4 Sep 2026 |
| Jennifer L. TaubertEVP, WWC. Innovative Medicine | sold | 15,000at $263.36 | 17 Aug 2026filed 18 Aug 2026 |
| Joaquin DuatoCEO and Chairman of the Board | sold | 20,976at $262.00 | 13 Aug 2026filed 14 Aug 2026 |
| Joaquin DuatoCEO and Chairman of the Board | sold | 102,315at $261.00 | 13 Aug 2026filed 14 Aug 2026 |
| Elizabeth ForminardEVP, Chief Legal Officer | sold | 9,344at $257.76 | 6 Aug 2026filed 7 Aug 2026 |
| Elizabeth ForminardEVP, Chief Legal Officer | sold | 6,574at $255.93 | 6 Aug 2026filed 7 Aug 2026 |
| Joaquin DuatoCEO and Chairman of the Board | sold | 41,957at $258.06 | 5 Aug 2026filed 7 Aug 2026 |
| Joaquin DuatoCEO and Chairman of the Board | sold | 6,523at $258.74 | 5 Aug 2026filed 7 Aug 2026 |
| Vanessa BroadhurstEVP, Global Corp Affairs | sold | 23,054at $251.27 | 20 Jul 2026filed 21 Jul 2026 |
| Kathryn E. WengelEVP, Chief TO and Risk Officer | sold | 10,000at $241.15 | 11 Jun 2026filed 12 Jun 2026 |
| Robert J. DeckerVP Corporate Controller | sold | 4,075at $247.87 | 27 Feb 2026filed 3 Mar 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Still reading this part; it fills in a moment.
News
Johnson & Johnson Just Raised Its Sales Outlook Again. Here's Why the Dividend King Is Still a Buy.fool.com · 17 Oct 2026Johnson & Johnson: 3 Key Takeaways for Long-Term Investorsfool.com · 16 Oct 2026Dividend Roundup: Johnson & Johnson, Coca-Cola, Costco, CVS Health, and moreseekingalpha.com · 16 Oct 2026Johnson & Johnson High Wycombe office redevelopment approvedbucksfreepress.co.uk · 16 Oct 2026Johnson & Johnson Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Johnson & Johnson (JNJ)aol.com · 14 Oct 2026Johnson & Johnson PR: Tylenol Recall to Talc Settlementeverything-pr.com · 14 Oct 2026Johnson & Johnson Investigation Initiated: Levi & Korsinsky Investigates ...pr-inside.com · 14 Oct 2026Johnson & Johnson leaning toward spinning out hips-and-knees business - WSJ (JNJ:NYSE)seekingalpha.com · 14 Oct 2026
Everyone who traded it
Same industry
Government contracts
Awards23
Total$1.0M
Latest1 Oct 2026
EO 14398 - BPA FOR VARIOUS MEDICAL SUPPLIES FOR THE MEDICAL SUPPLY DEPARTMENTDepartment of Health and Human Services · $100K · 1 Oct 2026INTEGRATED SURGICAL ENERGY PLATFORM SYSTEMDepartment of Veterans Affairs · $109K · 1 Sep 20264572376587!STARDRIVE SCREWDRIVER SHAFT T8Department of Defense · $1,267 · 13 Jul 20264572339114!VA-LCP CLAVICLE PLATE 2.7, SHAFT, CS3, LDepartment of Defense · $4,613 · 8 Jul 2026
From its SEC filings
Analyst forecasts
No analyst forecasts yet.